Tarsus Pharmaceuticals Inc
TARS
Insidertransaktionen und Aktienkurs 2024-2026
Alle Insidertrades bei Tarsus Pharmaceuticals Inc
| Datum |
Typ |
Insider |
Position |
Ø-Preis |
Volumen |
|
2.9.2026
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
80,1 $ |
800.600 $ |
|
2.9.2026
|
Verkauf |
Lin, Elizabeth Yeu |
Chief Medical Officer |
80,0 $ |
558.160 $ |
|
1.9.2026
|
Verkauf |
Lin, Elizabeth Yeu |
Chief Medical Officer |
73,9 $ |
339.830 $ |
|
17.6.2026
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
61,5 $ |
615.489 $ |
|
16.6.2026
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
61,0 $ |
877.436 $ |
|
15.6.2026
|
Verkauf |
Link, William J Phd |
Aufsichtsrat |
62,4 $ |
776.495 $ |
|
15.6.2026
|
Verkauf |
Goodrich, Katherine |
Aufsichtsrat |
62,1 $ |
183.384 $ |
|
20.3.2026
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
66,8 $ |
199.516 $ |
|
19.3.2026
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
67,0 $ |
146.462 $ |
|
19.3.2026
|
Verkauf |
Mottiwala, Aziz |
Chief Commercial Officer |
67,0 $ |
297.480 $ |
|
19.3.2026
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
67,0 $ |
307.463 $ |
|
19.3.2026
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
67,0 $ |
801.588 $ |
|
19.3.2026
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
67,0 $ |
279.658 $ |
|
19.3.2026
|
Verkauf |
Wahl, Bryan |
General Counsel |
67,0 $ |
283.477 $ |
|
19.3.2026
|
Verkauf |
Lin, Elizabeth Yeu |
Chief Medical Officer |
67,0 $ |
26.130 $ |
|
18.3.2026
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
68,7 $ |
146.558 $ |
|
18.3.2026
|
Verkauf |
Mottiwala, Aziz |
Chief Commercial Officer |
68,7 $ |
297.514 $ |
|
18.3.2026
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
68,7 $ |
248.043 $ |
|
18.3.2026
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
68,7 $ |
801.640 $ |
|
18.3.2026
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
68,7 $ |
279.718 $ |
|
18.3.2026
|
Verkauf |
Wahl, Bryan |
General Counsel |
68,7 $ |
283.429 $ |
|
18.3.2026
|
Verkauf |
Lin, Elizabeth Yeu |
Chief Medical Officer |
68,7 $ |
26.041 $ |
|
17.3.2026
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
69,4 $ |
146.546 $ |
|
17.3.2026
|
Verkauf |
Mottiwala, Aziz |
Chief Commercial Officer |
69,4 $ |
297.534 $ |
|
17.3.2026
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
69,4 $ |
216.938 $ |
|
17.3.2026
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
69,4 $ |
761.676 $ |
|
17.3.2026
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
69,4 $ |
279.693 $ |
|
17.3.2026
|
Verkauf |
Wahl, Bryan |
General Counsel |
69,4 $ |
283.511 $ |
|
17.3.2026
|
Verkauf |
Lin, Elizabeth Yeu |
Chief Medical Officer |
69,4 $ |
26.033 $ |
|
16.3.2026
|
Verkauf |
Link, William J Phd |
Aufsichtsrat |
69,0 $ |
859.819 $ |
|
4.3.2026
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
76,7 $ |
641.421 $ |
|
2.1.2026
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
81,4 $ |
1.255.684 $ |
|
24.12.2025
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
83,0 $ |
495.090 $ |
|
16.12.2025
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
80,1 $ |
592.500 $ |
|
16.12.2025
|
Verkauf |
Lin, Elizabeth Yeu |
Chief Medical Officer |
79,5 $ |
165.201 $ |
|
15.12.2025
|
Verkauf |
Link, William J Phd |
Aufsichtsrat |
81,4 $ |
1.864.679 $ |
|
24.9.2025
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
55,4 $ |
332.220 $ |
|
8.9.2025
|
Verkauf |
Link, William J Phd |
Aufsichtsrat |
57,0 $ |
1.545.612 $ |
|
11.8.2025
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
50,0 $ |
300.000 $ |
|
17.6.2025
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
40,4 $ |
550.035 $ |
|
16.6.2025
|
Verkauf |
Lin, Elizabeth Yeu |
Chief Medical Officer |
41,1 $ |
41.326 $ |
|
9.6.2025
|
Verkauf |
Mottiwala, Aziz |
Chief Commercial Officer |
43,8 $ |
765.800 $ |
|
24.3.2025
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
50,0 $ |
300.000 $ |
|
20.3.2025
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
50,1 $ |
59.430 $ |
|
20.3.2025
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
50,1 $ |
427.639 $ |
|
20.3.2025
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
50,1 $ |
107.085 $ |
|
20.3.2025
|
Verkauf |
Wahl, Bryan |
General Counsel |
50,1 $ |
154.539 $ |
|
20.3.2025
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
50,1 $ |
122.018 $ |
|
20.3.2025
|
Verkauf |
Mottiwala, Aziz |
Chief Commercial Officer |
50,1 $ |
168.620 $ |
|
19.3.2025
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
47,4 $ |
59.440 $ |
|
19.3.2025
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
47,4 $ |
405.317 $ |
|
19.3.2025
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
47,4 $ |
107.077 $ |
|
19.3.2025
|
Verkauf |
Wahl, Bryan |
General Counsel |
47,4 $ |
154.571 $ |
|
19.3.2025
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
47,4 $ |
120.538 $ |
|
19.3.2025
|
Verkauf |
Mottiwala, Aziz |
Chief Commercial Officer |
47,4 $ |
168.602 $ |
|
18.3.2025
|
Verkauf |
Farrow, Jeffrey S. |
Vorstand |
46,3 $ |
59.436 $ |
|
18.3.2025
|
Verkauf |
Azamian, Bobak R. |
President/CEO and Board Chair |
46,3 $ |
330.094 $ |
|
18.3.2025
|
Verkauf |
Whitfield, Dianne C. |
Chief Human Resources Officer |
46,3 $ |
107.161 $ |
|
18.3.2025
|
Verkauf |
Wahl, Bryan |
General Counsel |
46,3 $ |
154.655 $ |
|
18.3.2025
|
Verkauf |
Neervannan, Seshadri |
Chief Operating Officer |
46,3 $ |
120.585 $ |
|
18.3.2025
|
Verkauf |
Mottiwala, Aziz |
Chief Commercial Officer |
46,3 $ |
168.634 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)
Kostenlose Updates per Mail
Bestätige noch deine Email-Adresse